MyFinsight
Home
Blog
About
Personalis, Inc. (PSNL)
Personalis, Inc. (PSNL)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$29,552K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of avai...
Accrued and other current liabil...
Accounts payable
Others
Negative Cash Flow Breakdown
Purchases of available-for-sale ...
Payroll and related costs
Other segment items
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
22,357
15,472
17,345
52,303
Payroll and related costs
24,480
22,287
17,406
52,589
Lab supplies and outside services
3,501
2,234
3,614
10,595
Facility costs
2,495
2,370
2,605
7,329
Professional services
4,751
3,819
2,907
8,341
Repairs and maintenance
2,756
2,615
2,427
6,381
Change in fair value of the tempus warrants
-
-
0
0
Depreciation and amortization
2,474
2,311
2,264
7,523
Other segment items
15,549
12,040
11,504
22,588
Interest income
1,966
2,172
1,570
5,585
Net loss
-31,683
-30,032
-23,812
-21,652
Stock-based compensation expense
3,981
2,553
2,298
2,082
Depreciation and amortization
2,414
2,371
2,462
2,466
Noncash operating lease cost
97
161
131
405
Amortization of discount on short-term investments
1,066
1,125
845
942
Other
-34
-21
73
-34
Accounts receivable
2,080
-3,181
1,827
4,424
Inventories and other deferred costs
2,709
786
1,488
-780
Prepaid expenses and other assets
2,532
-663
949
142
Accounts payable
4,628
-809
1,819
-990
Accrued and other current liabilities
4,723
-426
1,782
1,818
Contract liabilities
-773
2,606
106
-169
Operating lease liabilities
-804
-856
-800
-1,020
Other long-term liabilities
-
-
-1,050
-50
Net cash used in operating activities
-25,770
-22,478
-22,246
-21,804
Purchases of available-for-sale debt securities
27,155
67,040
53,727
48,150
Proceeds from maturities of available-for-sale debt securities
69,100
24,100
39,425
68,500
Purchases of property and equipment
3,782
3,192
77
1,626
Proceeds from sales of property and equipment
0
120
-
-
Net cash used in investing activities
38,163
-46,012
-14,379
18,724
Proceeds from sales of common stock under atm facility, net of commissions
4,551
20,952
109,015
0
Payment of costs related to tempus and merck investment agreements
-
-
83
0
Proceeds from loans
-
-
0
0
Repayments of loans and finance lease
158
1,278
284
411
Payments for finance lease buyout
0
2,125
-
-
Proceeds from issuance of common stock under equity incentive plans
3,595
281
2,247
94
Net cash provided by financing activities
7,988
17,830
110,895
-317
Effect of exchange rates on cash, cash equivalents and restricted cash
-7
9
2
-4
Net change in cash, cash equivalents and restricted cash
20,374
-50,651
74,272
-3,401
Cash, cash equivalents and restricted cash, beginning of period
75,384
126,035
51,763
93,205
Cash, cash equivalents and restricted cash, end of period
95,758
75,384
126,035
51,763
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of...
$69,100K
(-17.92%↓ Y/Y)
Proceeds from sales of
common stock under atm...
$4,551K
(-74.41%↓ Y/Y)
Proceeds from issuance of
common stock under...
$3,595K
(347.14%↑ Y/Y)
Net cash used in
investing activities
$38,163K
(241.80%↑ Y/Y)
Net cash provided by
financing activities
$7,988K
(-59.57%↓ Y/Y)
Canceled cashflow
$30,937K
Canceled cashflow
$158K
Net change in cash,
cash equivalents and...
$20,374K
(153.56%↑ Y/Y)
Canceled cashflow
$25,777K
Purchases of
available-for-sale debt securities
$27,155K
(-74.93%↓ Y/Y)
Purchases of property and
equipment
$3,782K
(35.02%↑ Y/Y)
Accrued and other
current liabilities
$4,723K
(464.99%↑ Y/Y)
Accounts payable
$4,628K
(24.38%↑ Y/Y)
Stock-based compensation
expense
$3,981K
(-21.15%↓ Y/Y)
Depreciation and
amortization
$2,414K
(-52.83%↓ Y/Y)
Noncash operating lease
cost
$97K
(-87.86%↓ Y/Y)
Other
-$34K
(-112.93%↓ Y/Y)
Repayments of loans and
finance lease
$158K
(-87.91%↓ Y/Y)
Net cash used in
operating activities
-$25,770K
(16.59%↑ Y/Y)
Effect of exchange
rates on cash, cash...
-$7K
(-187.50%↓ Y/Y)
Canceled cashflow
$15,877K
Revenue
$22,357K
Interest income
$1,966K
Net loss
-$31,683K
(11.51%↑ Y/Y)
Canceled cashflow
$24,323K
Inventories and other
deferred costs
$2,709K
(637.50%↑ Y/Y)
Prepaid expenses and
other assets
$2,532K
(123.48%↑ Y/Y)
Accounts receivable
$2,080K
(14.79%↑ Y/Y)
Amortization of discount on
short-term investments
$1,066K
(-51.63%↓ Y/Y)
Operating lease
liabilities
-$804K
(59.80%↑ Y/Y)
Contract liabilities
-$773K
(47.59%↑ Y/Y)
Payroll and related
costs
$24,480K
Other segment items
$15,549K
Professional services
$4,751K
Lab supplies and
outside services
$3,501K
Repairs and maintenance
$2,756K
Facility costs
$2,495K
Depreciation and
amortization
$2,474K
(-51.66%↓ Y/Y)
Buy us a coffee